Home > Exhibition > Content
▶ JUN, 21 - 23 , 2016|China CPHI |Shanghai,China
Apr 07, 2016

There are nearly 5000 pharmaceutical enterprises in China, and more than 90% of generic drugs enterprises. Around 2018, China's generic drug market will undergo major adjustments in the face of policy changes and intensified competition. The CPhI Sixth China counterfeit drug summit, sponsored by China, will focus on "changing policy environment and fierce competition pattern", gathering the essence of CPhI global resources and the previous five summits, and further excavating and exploring the key points of generic pharmaceutical policies and regulations, market and competition, research and development and technology. Professionals in the field of generic medicine both at home and abroad provide a platform for communication and presentation to promote international cooperation and interaction.